Thrombotic risk in hepatitis C: Interplay between hepatic dysfunction, viral-driven inflammation, and cardiovascular consequences

doi:10.5501/wjv.v14.i4.113217

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 4

This Article

(41)

(46)

(0)

(8)

(629)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Virol. Dec 25, 2025; 14(4): 113217
Published online Dec 25, 2025. doi: 10.5501/wjv.v14.i4.113217

Full Size Figure Download Figure

Figure 2 Biomarkers and risk stratification in hepatitis C virus-associated thrombosis. Candidate biomarkers - including interleukin-6, tumor necrosis factor-α, high-sensitivity C-reactive protein, D-dimer, von Willebrand factor, N-terminal pro-B-type natriuretic peptide, and factor VIII - may provide prognostic value for assessing cardiovascular and thrombotic risk in patients with chronic hepatitis C virus infection. HCV: Hepatitis C virus; IL-6: Interleukin-6; TNF-α: Tumor necrosis factor-α; hs-CRP: High-sensitivity C-reactive protein; NT-proBNP: N-terminal pro B-type natriuretic peptid.

Citation: Zohery M, Jahangir S, Jenna HC, Sarfraz S, Ali H, Raza M, Rafiq T, Dahiya DS, Jahagirdar V, Ali H. Thrombotic risk in hepatitis C: Interplay between hepatic dysfunction, viral-driven inflammation, and cardiovascular consequences. World J Virol 2025; 14(4): 113217
URL: https://www.wjgnet.com/2220-3249/full/v14/i4/113217.htm
DOI: https://dx.doi.org/10.5501/wjv.v14.i4.113217

Zohery M, Jahangir S, Jenna HC, Sarfraz S, Ali H, Raza M, Rafiq T, Dahiya DS, Jahagirdar V, Ali H. Thrombotic risk in hepatitis C: Interplay between hepatic dysfunction, viral-driven inflammation, and cardiovascular consequences. World J Virol 2025; 14(4): 113217 [PMID: 41479579 DOI: 10.5501/wjv.v14.i4.113217]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.